These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16390241

  • 1. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM.
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [Abstract] [Full Text] [Related]

  • 2. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC.
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [Abstract] [Full Text] [Related]

  • 3. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR, Chow P.
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [Abstract] [Full Text] [Related]

  • 4. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D, Aragona F, Guarnotta C, Rodolico V, Zerilli M, Belmonte B, Schillaci L, Aragona F.
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL, Garrod DR, Madani S, Buchanan MD, Clark RE.
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [Abstract] [Full Text] [Related]

  • 6. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
    Berger F, Geddert H, Faller G, Werner M, Dimmler A.
    Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
    [Abstract] [Full Text] [Related]

  • 7. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
    Kuivanen TT, Jeskanen L, Kyllönen L, Impola U, Saarialho-Kere UK.
    Mod Pathol; 2006 Sep; 19(9):1203-12. PubMed ID: 16699496
    [Abstract] [Full Text] [Related]

  • 8. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S, Di Felice E, Cabras S, Castellanos ME, Atzori L, Faa G, Pilloni L.
    Eur J Histochem; 2013 Feb 14; 57(1):e6. PubMed ID: 23549465
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A, Smoller BR.
    Mod Pathol; 2002 Nov 14; 15(11):1121-5. PubMed ID: 12429789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA, Ross JS, Boehm JR, Carlson JA.
    J Cutan Pathol; 1999 Sep 14; 26(8):391-7. PubMed ID: 10551411
    [Abstract] [Full Text] [Related]

  • 12. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R, Martínez-Barba E, López-Poveda MJ, Vidal-Abarca Gutiérrez I, Ruíz-Maciá JA, Oviedo-Ramirez I, Martínez-Menchón T.
    Actas Dermosifiliogr; 2012 May 14; 103(4):308-16. PubMed ID: 22176864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC, Magalhães RF, de Moraes AM, Stelini RF, Cintra GF, Metze K, Cintra ML.
    Medicine (Baltimore); 2015 Jun 14; 94(23):e934. PubMed ID: 26061320
    [Abstract] [Full Text] [Related]

  • 19. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND, Smoller BR, Morgan M.
    Mod Pathol; 2003 Jan 14; 16(1):8-13. PubMed ID: 12527707
    [Abstract] [Full Text] [Related]

  • 20. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
    Vasiljević N, Andersson K, Bjelkenkrantz K, Kjellström C, Månsson H, Nilsson E, Landberg G, Dillner J, Forslund O.
    Int J Cancer; 2009 May 15; 124(10):2361-6. PubMed ID: 19165861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.